BAMS
GEVA

Bellevue Asset Management (Switzerland)’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-14,900
Closed -$1.45M – 154
2015
Q1 		$1.45M Buy
+14,900
New +$1.45M 0.2% 105